CellMaxx 

MP Biomedicals’ new CellMaxx Bovine products are obtained from New Zealand sources and prepared to final specification in New Zealand in an ISO quality system. New Zealand has the highest possible biosafety level with negligible BSE risk. This classification provides the greatest risk mitigation and the greatest assurance that cells will not be exposed to harmful biological agents. State-of-the-art chromatographic extraction ensures high purity, intact proteins, processed without the denaturing effect of heat or solvents used in more traditional methods. The combination of the technology performed in an ISO quality system ensure a high level of process control and product consistency, meeting the stringent demands of the bio-pharmaceutical industry.